查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1922992

PVC血袋市场按产品类型、血液成分、灭菌技术、连接埠配置、价格范围、应用、最终用户和销售管道划分－2026-2032年全球预测

PVC Blood Bags Market by Product Type, Blood Component, Sterilization Technique, Port Configuration, Price Range, Application, End User, Sales Channel - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 195 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计到 2025 年，聚氯乙烯血袋市场价值将达到 15.2 亿美元，到 2026 年将成长至 16.1 亿美元，到 2032 年将达到 22.8 亿美元，复合年增长率为 5.92%。

关键市场统计数据
基准年 2025 15.2亿美元
预计年份：2026年 16.1亿美元
预测年份 2032 22.8亿美元
复合年增长率 (%) 5.92%

本文对PVC血袋的功能、临床效用以及影响采购和临床实践的营运驱动因素进行了简明扼要而又全面的概述。

PVC血袋产业处于临床需求与製造精准度的交会点，材料科学、严格的灭菌製程与供应链的完整性在此汇聚，共同保障输血服务的安全。本文概述了PVC血袋在现代血液管理系统中的功能作用，重点阐述了设备配置、组件相容性和灭菌途径如何直接影响临床工作流程和库存管理。此外，我们还建立了一个框架，用于分析影响采购决策的关键因素，包括与血浆分离系统的兼容性、白血球去除的必要性以及不同门诊中心、医院血库和诊断机构终端用户需求的差异，从而为后续分析奠定基础。

近期技术进步、采购行为转变以及灭菌技术创新如何重塑供应策略和临床工作流程

随着临床需求、监管要求和生产能力的调整，PVC血袋市场环境正在迅速变化。针对特定血液成分的血袋设计不断进步，包括更先进的血小板和血浆密封技术以及改进的端口配置，这些都改变了血站和医院标准化库存和优化工作流程的方式。同时，灭菌技术的创新，特别是非热灭菌技术，降低了与温度和时间敏感型流程相关的物流限制，并实现了更广泛的地域采购。这些技术变革，加上对捐血安全日益重视材料和流程可追溯性的要求，正在提高供应链透明度的标准。

评估近期贸易政策和关税执行的变化如何影响关键医疗设备的筹资策略、供应商伙伴关係和供应链韧性。

近期进口政策调整导致的关税措施对PVC血袋供应链动态产生了多方面的影响，波及采购决策、库存策略和供应商关係。进口关税的提高增加了某些产品类型的到岸成本，迫使医院和血库重新评估其国内和国际采购之间的平衡。为此，一些机构正在深化与区域加工商和灭菌供应商的商业性伙伴关係，以减轻跨境课税波动的影响。同时，其他机构则在增加安全库存，以应对短期价格波动和潜在的前置作业时间波动。

详细的細項分析揭示了产品组合、组件特性、灭菌方法偏好和销售管道如何决定需求、风险和采购优先顺序。

市场区隔为理解PVC血袋生态系中的价值和风险集中领域提供了必要的分析架构。产品和应用类别之间的细微差别揭示了不同的需求模式和技术要求。基于产品类型的市场结构包括双袋、四袋、单袋和三袋配置，每种配置都针对特定的分离和储存流程进行了最佳化。多袋组合在成分分离和处理方面提高了操作效率。基于血液成分的分类包括冷冻血浆袋、血浆袋、血小板袋和红血球袋。血浆袋又细分为新鲜冷冻和冷冻两种类型，而血小板袋则分为单采血小板袋和随机供血血小板袋。红血球袋则分为白血球去除和未去除两种选择，这既反映了临床需求，也体现了处理的复杂性。

影响采购行为、供应商在地化策略和监管应对措施的区域趋势（美洲、欧洲、中东和非洲、亚太地区）

区域趋势影响供应链结构、监管互动和采购政策。了解关键区域之间的差异，有助于明确策略投资和伙伴关係将在哪些领域产生最大影响。在美洲，临床网路往往优先考虑营运规模和一体化物流，而大型医院系统和中央血库则优先考虑多袋解决方案和检验的灭菌流程，以支援高通量处理和强大的可追溯性。区域内的跨境贸易和已建立的本地製造能力影响筹资策略，而报销机制和医院采购惯例则影响商业谈判。

竞争定位和营运模式强调製造技术专长、灭菌伙伴关係关係和综合服务产品。

对主要企业模式和营运策略的检验表明，市场参与企业透过製造技术、灭菌伙伴关係和服务水准承诺来实现差异化。一些製造商专注于高通量挤出和组装能力，投资于多端口系统和专用材料以支援复杂的流程分离。另一些製造商则强调模组化和客製化，提供针对特定临床通讯协定（例如血液分离术和白血球分离术）量身定制的产品系列。同时，灭菌服务供应商和企业内部灭菌部门在市场准入方面发挥着至关重要的作用，与经认证的伽马射线、电子束和环氧乙烷灭菌设施建立合作关係往往决定着产品能否在全部区域推广。

在快速变化的临床供应链环境中，製造商和供应商可采取切实可行的策略措施，以提高其韧性、营运柔软性和客户协作能力。

在技​​术创新、采购趋势变化和贸易政策转变的背景下，行业领导者必须采取果断行动，以维持医疗保健服务的连续性并确保可持续的商业性优势。首先，投资于灵活的生产製造和检验的灭菌伙伴关係关係，可以降低单一来源供应中断的风险，并能够快速调整产品线以适应不断变化的临床通讯协定。其次，透过客製化的服务和快速回应的技术支援来加强与终端用户的关係，可以加速多袋解决方案的推广应用，并降低产品替代的风险。第三，实现销售管道多元化，平衡直销、分销网络和线上采购平台，可以在保持价格稳定的同时缩短订单交货週期。

采用稳健的多方法研究途径，结合相关人员访谈、技术检验和供应链诊断，以产生可操作的见解和可复製的结论。

本执行摘要的研究采用了一种多方面的方法，结合了与关键相关人员的对话、技术文件审查和供应链诊断，以得出可操作的见解。主要研究包括对采购主管、血库经理和灭菌服务提供者进行结构化访谈，以了解他们的营运、产品偏好和供应商选择标准。除了这些定性资讯外，还对监管指南、设备规格和灭菌检验文献进行了系统性审查，以确保技术准确性并识别因地区而异的合规性考虑因素。

技术、监管和商业性要求的整合结果决定了供应商和买家应如何优先考虑韧性、验证和相关人员参与。

对临床需求、技术能力和商业策略的综合分析凸显了适应性强的产品设计、检验的灭菌途径和稳健的供应链对于维持安全高效的血液管理至关重要。主要研究结果表明，从端口数量到血袋组装等配置选择，都与灭菌方法和终端用户工作流程相互作用，共同决定了采购标准。贸易政策的变化提升了本地製造和一体化灭菌伙伴关係的价值，而不断发展的采购管道则提高了透明度并加快了订单履行速度。总而言之，这些趋势既为製造商、服务供应商和医疗保健采购商带来了风险，也带来了机会。

目录

第一章：序言

第二章调查方法

  • 研究设计
  • 研究框架
  • 市场规模预测
  • 数据三角测量
  • 调查结果
  • 调查前提
  • 调查限制

第三章执行摘要

  • 首席主管观点
  • 市场规模和成长趋势
  • 2025年市占率分析
  • FPNV定位矩阵，2025
  • 新的商机
  • 下一代经营模式
  • 产业蓝图

第四章 市场概览

  • 产业生态系与价值链分析
  • 波特五力分析
  • PESTEL 分析
  • 市场展望
  • 上市策略

第五章 市场洞察

  • 消费者洞察与终端用户观点
  • 消费者体验基准
  • 机会地图
  • 分销通路分析
  • 价格趋势分析
  • 监理合规和标准框架
  • ESG与永续性分析
  • 中断和风险情景
  • 投资报酬率和成本效益分析

第六章：美国关税的累积影响，2025年

第七章：人工智慧的累积影响，2025年

8. 依产品类型分類的PVC血袋市场

  • 双层袋
  • 四袋
  • 单袋
  • 米包

第九章 PVC血袋市场（依血液成分划分）

  • 冷沉淀袋
  • 血浆袋
    • 新鲜冷冻血浆
    • 冷冻
  • 血小板袋
    • 血液分离术
    • 随机捐赠者
  • 红血球袋
    • 白血球去除
    • 非白血球分离术

10. 依灭菌技术分類的PVC血袋市场

  • 电子束辐照
  • 环氧乙烷
  • 伽玛射线

11. 依港口配置分類的PVC血袋市场

  • 4个连接埠
  • 6个连接埠
  • 双埠

第十二章 PVC血袋市场价格区间

  • 经济
  • 优质的
  • 标准

第十三章 PVC血袋市场按应用领域划分

  • 收藏
  • 分离

第十四章 PVC血袋市场（依终端用户划分）

  • 门诊治疗中心
  • 血库
  • 诊断中心
  • 医院

第十五章 PVC血袋市场销售管道

  • 离线
  • 在线的

第十六章 各地区PVC血袋市场

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

第十七章 PVC血袋市场（依团体划分）

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第十八章 各国PVC血袋市场

  • 我们
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

第十九章：美国PVC血袋市场

第二十章：中国PVC血袋市场

第21章 竞争情势

  • 市场集中度分析，2025年
    • 浓度比（CR）
    • 赫芬达尔-赫希曼指数 (HHI)
  • 近期趋势及影响分析，2025 年
  • 2025年产品系列分析
  • 基准分析，2025 年
  • 3S Corporation
  • Adroit Manufacturing Company
  • Apolo Surgical
  • BL Life Sciences Pvt. Ltd.
  • Blue Neem Medical Devices Ltd
  • CY Medical Co., Ltd.
  • Deepee Cooling Products Pvt. Ltd.
  • Demotek Ltd.
  • Fresenius SE & Co. KGaA
  • General Cooperation Industry Co., Ltd.
  • Grifols, SA
  • HLL Lifecare Ltd.
  • Innvol Medical India Ltd.
  • J. Mitra & Co. Pvt. Ltd.
  • JMS Co., Ltd.
  • Kawasumi Laboratories, Inc.
  • Kensure Healthcare Pvt. Ltd.
  • Maco Pharma International GmbH
  • Mitra Industries Pvt. Ltd.
  • Mohini Health & Hygiene Ltd.
  • Poly Medicure Ltd.
  • Shandong Weigao Group Medical Polymer Co., Ltd.
  • Terumo Corporation
Product Code: MRR-867BED9A9EAB

The PVC Blood Bags Market was valued at USD 1.52 billion in 2025 and is projected to grow to USD 1.61 billion in 2026, with a CAGR of 5.92%, reaching USD 2.28 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 1.52 billion
Estimated Year [2026] USD 1.61 billion
Forecast Year [2032] USD 2.28 billion
CAGR (%) 5.92%

A concise yet comprehensive orientation to PVC blood bag functionality, clinical utility, and the operational drivers shaping procurement and clinical practice

The PVC blood bag sector sits at the intersection of clinical necessity and manufacturing precision, where materials science, sterilization rigor, and supply-chain integrity converge to sustain safe transfusion services. This introduction outlines the functional role of PVC blood bags within modern blood management systems, emphasizing how device configuration, component compatibility, and sterilization pathways directly affect clinical workflows and inventory management. It establishes the context for subsequent analysis by framing the principal drivers influencing procurement decisions, such as compatibility with apheresis systems, the need for leucocyte reduction, and varying end-user requirements across ambulatory centers, hospital blood banks, and diagnostic facilities.

Moving from clinical context to operational implications, the narrative highlights how incremental improvements in bag design-port configurations, multi-bag assemblies, and specialized component compartments-translate into measurable improvements in handling, separation efficiency, and storage stability. It also underscores how sterilization techniques shape supply-chain choices because different decontamination approaches impose distinct validation and logistics demands. Throughout, the introduction stresses that stakeholder choices are governed not only by product attributes but by end-user workflows, regulatory compliance, and service-level expectations, creating a complex procurement environment that rewards clarity, standardization, and responsive supplier partnerships.

How recent technological advancements, procurement behavior changes, and sterilization innovations are reshaping supplier strategies and clinical workflows

The landscape for PVC blood bags has shifted rapidly as clinical priorities, regulatory expectations, and manufacturing capabilities have realigned. Advances in component-specific bag design, such as refined platelet and plasma containment features and improvements in port configurations, have altered how blood centers and hospitals think about inventory harmonization and workflow optimization. Simultaneously, sterilization innovations, particularly in non-thermal modalities, have enabled broader geographic sourcing by reducing some of the logistical constraints associated with temperature- or time-sensitive processes. These technological shifts have been complemented by greater emphasis on donor-safety compatible materials and process traceability, which collectively elevate the bar for supply-chain transparency.

Equally influential are changes in procurement behavior. End users now prioritize integrated solutions that reduce handling time and minimize cross-contamination risk, driving demand for multi-bag systems that facilitate component separation and targeted storage. At the same time, commercialization pathways are adapting as direct sales and distributor models coexist with an increasing share of digital procurement channels that offer faster order cycles and enhanced visibility. Regulatory scrutiny and quality assurance expectations have intensified, prompting manufacturers to invest in validated sterilization partnerships and robust documentation. Together, these transformative shifts are reshaping competitive positioning and compelling stakeholders to re-evaluate their sourcing and product selection frameworks.

Assessment of how recent shifts in trade policy and tariff implementation have altered sourcing strategies, supplier partnerships, and supply-chain resilience for critical medical devices

Recent tariff measures originating from changes in import policy have exerted multi-layered effects on supply-chain dynamics for PVC blood bags, creating ripple effects across sourcing decisions, inventory strategies, and supplier relationships. Increased import duties have raised landed costs for certain product classes, prompting hospitals and blood banks to reassess the balance between domestic sourcing and international procurement. In response, some organizations have sought deeper commercial partnerships with regional converters and sterilization vendors to mitigate exposure to cross-border levy fluctuations, while others have expanded safety stock to absorb short-term price instability and potential lead-time variability.

Beyond procurement costs, tariffs have influenced capacity planning and vendor qualification timelines. Procurement teams have recalibrated supplier selection criteria to prioritize partners with localized production or integrated sterilization capabilities that reduce the need for cross-border shipments subject to tariff schedules. This has encouraged strategic collaboration between manufacturers and sterilization service providers to create vertically aligned value chains that are inherently less sensitive to import duty volatility. Concurrently, regulatory certification and device traceability have become even more crucial as organizations seek to justify shifts in sourcing and to maintain seamless clinical operations amid changing trade policy landscapes.

In-depth segmentation analysis revealing how product configurations, component specializations, sterilization choices, and commercial channels define demand, risk, and procurement priorities

Segmentation provides the analytical scaffolding needed to understand where value and risk concentrate within the PVC blood bag ecosystem, and a nuanced reading of product and application categories reveals distinct demand patterns and technical requirements. Based on Product Type, the market encompasses Double Bag, Quadruple Bag, Single Bag, and Triple Bag configurations, each optimized for particular separation and storage flows, with multi-bag assemblies offering operational efficiencies in component isolation and handling. Based on Blood Component, the landscape includes Cryoprecipitate Bag, Plasma Bag, Platelet Bag, and Red Cell Bag; the Plasma Bag subdivides into Fresh Frozen and Frozen types, the Platelet Bag further differentiates into Apheresis and Random Donor variants, and the Red Cell Bag is characterized by Leucocyte Reduced and Non Leucocyte Reduced options, reflecting both clinical need and processing complexity.

Based on End User, devices are tailored for Ambulatory Care Centers, Blood Banks, Diagnostic Centers, and Hospitals, each presenting different procurement cycles, traceability expectations, and storage infrastructures. Based on Application, segmentation into Collection and Separation highlights the distinct regulatory and operational controls required during initial phlebotomy versus downstream component processing. Based on Sterilization Technique, options such as E Beam, Ethylene Oxide, and Gamma establish different validation pathways and logistics considerations. Based on Port Configuration, differentiated offerings like Four Port, Six Port, and Two Port systems address workflow ergonomics and tubing complexity. Based on Sales Channel, procurement can proceed through Direct Sales, Distributor relationships, Online platforms, or Retail Pharmacy access, all of which influence lead times and service agreements. Based on Price Range, products classified as Economy, Premium, and Standard reflect trade-offs between cost, feature set, and clinical support, shaping purchase decisions across the buyer spectrum.

Regional dynamics that influence procurement behavior, supplier localization strategies, and regulatory engagement across the Americas, EMEA, and Asia-Pacific

Regional dynamics shape supply-chain architecture, regulatory engagement, and procurement preferences, and appreciating the differences across major geographies clarifies where strategic investments and partnerships will yield the greatest impact. In the Americas, clinical networks often emphasize operational scale and integrated logistics, with large hospital systems and centralized blood banks prioritizing multi-bag solutions and validated sterilization pipelines to support high-throughput processing and robust traceability. Cross-border trade within the region and established local manufacturing capacity influence sourcing strategies, while reimbursement and hospital procurement practices shape commercial negotiations.

In Europe, Middle East & Africa, a diverse regulatory tapestry and varying levels of local manufacturing capacity create heterogenous procurement environments. Some healthcare systems prioritize stringent conformity assessment and supplier qualification, driving demand for premium validated solutions, while other markets within the region rely on imports and regional distributors to bridge capability gaps. In Asia-Pacific, rapid expansion of diagnostic and ambulatory services, combined with evolving regulatory frameworks, has accelerated uptake of both economy and advanced product segments. Local conversion capacity, increased investment in sterilization infrastructure, and a growing preference for digital procurement channels are reshaping how suppliers approach market entry and scale-up across this region.

Competitive positioning and operational models that determine success, emphasizing manufacturing specialization, sterilization partnerships, and integrated service delivery

A review of leading corporate models and operational strategies highlights how market participants differentiate through manufacturing specialization, sterilization partnerships, and service-level commitments. Some manufacturers concentrate on high-throughput extrusion and bag assembly capabilities, investing in multi-port systems and specialized materials to support complex separation workflows. Others emphasize modularity and customization, offering product families that align with specific clinical protocols such as apheresis or leucocyte reduction. In parallel, sterilization service providers and in-house sterilization operations play a critical role in enabling market access; partnerships with validated gamma, e-beam, or ethylene oxide facilities frequently determine whether a product can be deployed across targeted geographies.

Commercially, firms are blending direct-sales expertise with distributor networks and digital ordering platforms to balance reach and margin. Forward-looking companies are investing in traceability technologies, regulatory expertise, and post-market surveillance capabilities to reduce qualification friction for hospital procurement teams. Strategic alliances between converters, sterilization vendors, and logistics providers are emerging as a common approach to deliver end-to-end solutions that minimize handling risk and ensure consistent quality. These competitive arrangements underline the importance of flexibility in production and the ability to support varied end-user configurations across heterogeneous healthcare settings.

Practical strategic moves for manufacturers and suppliers to enhance resilience, operational flexibility, and customer alignment in a rapidly evolving clinical supply landscape

Industry leaders must act decisively to preserve continuity of care and to secure durable commercial advantage in an environment marked by technological innovation, evolving procurement preferences, and trade policy shifts. First, investing in flexible manufacturing and validated sterilization partnerships will reduce exposure to single-source disruptions and allow rapid reconfiguration of product lines to meet changing clinical protocols. Second, strengthening relationships with end users through tailored service offerings and responsive technical support will accelerate adoption of multi-bag solutions and reduce product substitution risk. Third, diversifying sales channels to balance direct sales with distributor networks and online procurement platforms can shorten order-to-delivery cycles while preserving price discipline.

Leaders should also enhance supply-chain transparency by implementing traceability systems that connect production, sterilization, and distribution milestones, thereby facilitating regulatory compliance and supporting post-market surveillance requirements. Additionally, scenario planning that incorporates trade-policy contingencies and alternative sourcing pathways will mitigate operational risks associated with tariff volatility. Finally, investing in clinical validation studies and user-centered design improvements can drive differentiation by demonstrating measurable workflow and safety benefits. These combined actions will support resilient supply chains, stronger customer relationships, and clearer value propositions in competitive procurement environments.

A robust multi-method research approach combining stakeholder interviews, technical validation, and supply-chain diagnostics to support actionable insights and replicable conclusions

The research underpinning this executive summary follows a multi-method approach that combines primary stakeholder engagement, technical document review, and supply-chain diagnostics to produce actionable insights. Primary research included structured interviews with procurement leaders, blood bank managers, and sterilization service operators to capture operational realities, product preferences, and vendor selection criteria. These qualitative inputs were complemented by a systematic review of regulatory guidance, device specifications, and sterilization validation literature to ensure technical accuracy and to surface compliance considerations relevant to different geographies.

Supply-chain diagnostics examined manufacturing footprints, sterilization capacity distributions, and distribution channel models to identify pressure points and resiliency options. Analysis emphasized cross-validation, ensuring that insights derived from interviews were corroborated against documented device specifications and operational metrics. Where appropriate, scenario analyses were used to explore the operational implications of trade-policy changes and supplier consolidation. The methodology prioritized transparency, replicability, and stakeholder relevance, enabling readers to understand the provenance of conclusions and to apply findings to procurement, manufacturing, and clinical decision-making.

Concluding synthesis of technical, regulatory, and commercial imperatives that define how suppliers and purchasers should prioritize resilience, validation, and stakeholder engagement

The synthesis of clinical needs, technological capability, and commercial strategy underscores the central importance of adaptable product design, validated sterilization pathways, and resilient supply chains for sustaining safe and efficient blood management. Key insights emphasize that configuration choices-ranging from port count to bag assemblies-interact with sterilization modality and end-user workflows to define procurement criteria. Trade-policy shifts have heightened the value of regional manufacturing and integrated sterilization partnerships, while evolving procurement channels are encouraging greater transparency and faster order fulfillment. Collectively, these dynamics create both risks and opportunities for manufacturers, service providers, and healthcare buyers.

In closing, stakeholders that prioritize modular production, robust sterilization validation, and proactive engagement with end users will be best positioned to navigate regulatory complexity and operational uncertainty. Strategic investments in traceability and scenario planning will further insulate operations from tariff and supply disruptions. The path forward favors organizations that combine technical excellence with commercial agility, enabling them to deliver consistent quality while responding to the changing demands of clinical partners and procurement organizations.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. PVC Blood Bags Market, by Product Type

  • 8.1. Double Bag
  • 8.2. Quadruple Bag
  • 8.3. Single Bag
  • 8.4. Triple Bag

9. PVC Blood Bags Market, by Blood Component

  • 9.1. Cryoprecipitate Bag
  • 9.2. Plasma Bag
    • 9.2.1. Fresh Frozen
    • 9.2.2. Frozen
  • 9.3. Platelet Bag
    • 9.3.1. Apheresis
    • 9.3.2. Random Donor
  • 9.4. Red Cell Bag
    • 9.4.1. Leucocyte Reduced
    • 9.4.2. Non Leucocyte Reduced

10. PVC Blood Bags Market, by Sterilization Technique

  • 10.1. E Beam
  • 10.2. Ethylene Oxide
  • 10.3. Gamma

11. PVC Blood Bags Market, by Port Configuration

  • 11.1. Four Port
  • 11.2. Six Port
  • 11.3. Two Port

12. PVC Blood Bags Market, by Price Range

  • 12.1. Economy
  • 12.2. Premium
  • 12.3. Standard

13. PVC Blood Bags Market, by Application

  • 13.1. Collection
  • 13.2. Separation

14. PVC Blood Bags Market, by End User

  • 14.1. Ambulatory Care Center
  • 14.2. Blood Bank
  • 14.3. Diagnostic Center
  • 14.4. Hospital

15. PVC Blood Bags Market, by Sales Channel

  • 15.1. Offline
  • 15.2. Online

16. PVC Blood Bags Market, by Region

  • 16.1. Americas
    • 16.1.1. North America
    • 16.1.2. Latin America
  • 16.2. Europe, Middle East & Africa
    • 16.2.1. Europe
    • 16.2.2. Middle East
    • 16.2.3. Africa
  • 16.3. Asia-Pacific

17. PVC Blood Bags Market, by Group

  • 17.1. ASEAN
  • 17.2. GCC
  • 17.3. European Union
  • 17.4. BRICS
  • 17.5. G7
  • 17.6. NATO

18. PVC Blood Bags Market, by Country

  • 18.1. United States
  • 18.2. Canada
  • 18.3. Mexico
  • 18.4. Brazil
  • 18.5. United Kingdom
  • 18.6. Germany
  • 18.7. France
  • 18.8. Russia
  • 18.9. Italy
  • 18.10. Spain
  • 18.11. China
  • 18.12. India
  • 18.13. Japan
  • 18.14. Australia
  • 18.15. South Korea

19. United States PVC Blood Bags Market

20. China PVC Blood Bags Market

21. Competitive Landscape

  • 21.1. Market Concentration Analysis, 2025
    • 21.1.1. Concentration Ratio (CR)
    • 21.1.2. Herfindahl Hirschman Index (HHI)
  • 21.2. Recent Developments & Impact Analysis, 2025
  • 21.3. Product Portfolio Analysis, 2025
  • 21.4. Benchmarking Analysis, 2025
  • 21.5. 3S Corporation
  • 21.6. Adroit Manufacturing Company
  • 21.7. Apolo Surgical
  • 21.8. B.L. Life Sciences Pvt. Ltd.
  • 21.9. Blue Neem Medical Devices Ltd
  • 21.10. C.Y. Medical Co., Ltd.
  • 21.11. Deepee Cooling Products Pvt. Ltd.
  • 21.12. Demotek Ltd.
  • 21.13. Fresenius SE & Co. KGaA
  • 21.14. General Cooperation Industry Co., Ltd.
  • 21.15. Grifols, S.A.
  • 21.16. HLL Lifecare Ltd.
  • 21.17. Innvol Medical India Ltd.
  • 21.18. J. Mitra & Co. Pvt. Ltd.
  • 21.19. JMS Co., Ltd.
  • 21.20. Kawasumi Laboratories, Inc.
  • 21.21. Kensure Healthcare Pvt. Ltd.
  • 21.22. Maco Pharma International GmbH
  • 21.23. Mitra Industries Pvt. Ltd.
  • 21.24. Mohini Health & Hygiene Ltd.
  • 21.25. Poly Medicure Ltd.
  • 21.26. Shandong Weigao Group Medical Polymer Co., Ltd.
  • 21.27. Terumo Corporation

LIST OF FIGURES

  • FIGURE 1. GLOBAL PVC BLOOD BAGS MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL PVC BLOOD BAGS MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL PVC BLOOD BAGS MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL PVC BLOOD BAGS MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL PVC BLOOD BAGS MARKET SIZE, BY BLOOD COMPONENT, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL PVC BLOOD BAGS MARKET SIZE, BY STERILIZATION TECHNIQUE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL PVC BLOOD BAGS MARKET SIZE, BY PORT CONFIGURATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL PVC BLOOD BAGS MARKET SIZE, BY PRICE RANGE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL PVC BLOOD BAGS MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL PVC BLOOD BAGS MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. GLOBAL PVC BLOOD BAGS MARKET SIZE, BY SALES CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL PVC BLOOD BAGS MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 13. GLOBAL PVC BLOOD BAGS MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 14. GLOBAL PVC BLOOD BAGS MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 15. UNITED STATES PVC BLOOD BAGS MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 16. CHINA PVC BLOOD BAGS MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL PVC BLOOD BAGS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL PVC BLOOD BAGS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL PVC BLOOD BAGS MARKET SIZE, BY DOUBLE BAG, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL PVC BLOOD BAGS MARKET SIZE, BY DOUBLE BAG, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL PVC BLOOD BAGS MARKET SIZE, BY DOUBLE BAG, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL PVC BLOOD BAGS MARKET SIZE, BY QUADRUPLE BAG, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL PVC BLOOD BAGS MARKET SIZE, BY QUADRUPLE BAG, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL PVC BLOOD BAGS MARKET SIZE, BY QUADRUPLE BAG, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL PVC BLOOD BAGS MARKET SIZE, BY SINGLE BAG, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL PVC BLOOD BAGS MARKET SIZE, BY SINGLE BAG, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL PVC BLOOD BAGS MARKET SIZE, BY SINGLE BAG, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL PVC BLOOD BAGS MARKET SIZE, BY TRIPLE BAG, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL PVC BLOOD BAGS MARKET SIZE, BY TRIPLE BAG, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL PVC BLOOD BAGS MARKET SIZE, BY TRIPLE BAG, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL PVC BLOOD BAGS MARKET SIZE, BY BLOOD COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL PVC BLOOD BAGS MARKET SIZE, BY CRYOPRECIPITATE BAG, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL PVC BLOOD BAGS MARKET SIZE, BY CRYOPRECIPITATE BAG, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL PVC BLOOD BAGS MARKET SIZE, BY CRYOPRECIPITATE BAG, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL PVC BLOOD BAGS MARKET SIZE, BY PLASMA BAG, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL PVC BLOOD BAGS MARKET SIZE, BY PLASMA BAG, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL PVC BLOOD BAGS MARKET SIZE, BY PLASMA BAG, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL PVC BLOOD BAGS MARKET SIZE, BY PLASMA BAG, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL PVC BLOOD BAGS MARKET SIZE, BY FRESH FROZEN, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL PVC BLOOD BAGS MARKET SIZE, BY FRESH FROZEN, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL PVC BLOOD BAGS MARKET SIZE, BY FRESH FROZEN, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL PVC BLOOD BAGS MARKET SIZE, BY FROZEN, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL PVC BLOOD BAGS MARKET SIZE, BY FROZEN, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL PVC BLOOD BAGS MARKET SIZE, BY FROZEN, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL PVC BLOOD BAGS MARKET SIZE, BY PLATELET BAG, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL PVC BLOOD BAGS MARKET SIZE, BY PLATELET BAG, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL PVC BLOOD BAGS MARKET SIZE, BY PLATELET BAG, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL PVC BLOOD BAGS MARKET SIZE, BY PLATELET BAG, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL PVC BLOOD BAGS MARKET SIZE, BY APHERESIS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL PVC BLOOD BAGS MARKET SIZE, BY APHERESIS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL PVC BLOOD BAGS MARKET SIZE, BY APHERESIS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL PVC BLOOD BAGS MARKET SIZE, BY RANDOM DONOR, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL PVC BLOOD BAGS MARKET SIZE, BY RANDOM DONOR, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL PVC BLOOD BAGS MARKET SIZE, BY RANDOM DONOR, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL PVC BLOOD BAGS MARKET SIZE, BY RED CELL BAG, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL PVC BLOOD BAGS MARKET SIZE, BY RED CELL BAG, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL PVC BLOOD BAGS MARKET SIZE, BY RED CELL BAG, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL PVC BLOOD BAGS MARKET SIZE, BY RED CELL BAG, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL PVC BLOOD BAGS MARKET SIZE, BY LEUCOCYTE REDUCED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL PVC BLOOD BAGS MARKET SIZE, BY LEUCOCYTE REDUCED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL PVC BLOOD BAGS MARKET SIZE, BY LEUCOCYTE REDUCED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL PVC BLOOD BAGS MARKET SIZE, BY NON LEUCOCYTE REDUCED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL PVC BLOOD BAGS MARKET SIZE, BY NON LEUCOCYTE REDUCED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL PVC BLOOD BAGS MARKET SIZE, BY NON LEUCOCYTE REDUCED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL PVC BLOOD BAGS MARKET SIZE, BY STERILIZATION TECHNIQUE, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL PVC BLOOD BAGS MARKET SIZE, BY E BEAM, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL PVC BLOOD BAGS MARKET SIZE, BY E BEAM, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL PVC BLOOD BAGS MARKET SIZE, BY E BEAM, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL PVC BLOOD BAGS MARKET SIZE, BY ETHYLENE OXIDE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL PVC BLOOD BAGS MARKET SIZE, BY ETHYLENE OXIDE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL PVC BLOOD BAGS MARKET SIZE, BY ETHYLENE OXIDE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL PVC BLOOD BAGS MARKET SIZE, BY GAMMA, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL PVC BLOOD BAGS MARKET SIZE, BY GAMMA, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL PVC BLOOD BAGS MARKET SIZE, BY GAMMA, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL PVC BLOOD BAGS MARKET SIZE, BY PORT CONFIGURATION, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL PVC BLOOD BAGS MARKET SIZE, BY FOUR PORT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL PVC BLOOD BAGS MARKET SIZE, BY FOUR PORT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL PVC BLOOD BAGS MARKET SIZE, BY FOUR PORT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL PVC BLOOD BAGS MARKET SIZE, BY SIX PORT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL PVC BLOOD BAGS MARKET SIZE, BY SIX PORT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL PVC BLOOD BAGS MARKET SIZE, BY SIX PORT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL PVC BLOOD BAGS MARKET SIZE, BY TWO PORT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL PVC BLOOD BAGS MARKET SIZE, BY TWO PORT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL PVC BLOOD BAGS MARKET SIZE, BY TWO PORT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL PVC BLOOD BAGS MARKET SIZE, BY PRICE RANGE, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL PVC BLOOD BAGS MARKET SIZE, BY ECONOMY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL PVC BLOOD BAGS MARKET SIZE, BY ECONOMY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL PVC BLOOD BAGS MARKET SIZE, BY ECONOMY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL PVC BLOOD BAGS MARKET SIZE, BY PREMIUM, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL PVC BLOOD BAGS MARKET SIZE, BY PREMIUM, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL PVC BLOOD BAGS MARKET SIZE, BY PREMIUM, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL PVC BLOOD BAGS MARKET SIZE, BY STANDARD, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL PVC BLOOD BAGS MARKET SIZE, BY STANDARD, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL PVC BLOOD BAGS MARKET SIZE, BY STANDARD, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL PVC BLOOD BAGS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL PVC BLOOD BAGS MARKET SIZE, BY COLLECTION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL PVC BLOOD BAGS MARKET SIZE, BY COLLECTION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL PVC BLOOD BAGS MARKET SIZE, BY COLLECTION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL PVC BLOOD BAGS MARKET SIZE, BY SEPARATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL PVC BLOOD BAGS MARKET SIZE, BY SEPARATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL PVC BLOOD BAGS MARKET SIZE, BY SEPARATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL PVC BLOOD BAGS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 87. GLOBAL PVC BLOOD BAGS MARKET SIZE, BY AMBULATORY CARE CENTER, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 88. GLOBAL PVC BLOOD BAGS MARKET SIZE, BY AMBULATORY CARE CENTER, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 89. GLOBAL PVC BLOOD BAGS MARKET SIZE, BY AMBULATORY CARE CENTER, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 90. GLOBAL PVC BLOOD BAGS MARKET SIZE, BY BLOOD BANK, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 91. GLOBAL PVC BLOOD BAGS MARKET SIZE, BY BLOOD BANK, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 92. GLOBAL PVC BLOOD BAGS MARKET SIZE, BY BLOOD BANK, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 93. GLOBAL PVC BLOOD BAGS MARKET SIZE, BY DIAGNOSTIC CENTER, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 94. GLOBAL PVC BLOOD BAGS MARKET SIZE, BY DIAGNOSTIC CENTER, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 95. GLOBAL PVC BLOOD BAGS MARKET SIZE, BY DIAGNOSTIC CENTER, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 96. GLOBAL PVC BLOOD BAGS MARKET SIZE, BY HOSPITAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 97. GLOBAL PVC BLOOD BAGS MARKET SIZE, BY HOSPITAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 98. GLOBAL PVC BLOOD BAGS MARKET SIZE, BY HOSPITAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 99. GLOBAL PVC BLOOD BAGS MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 100. GLOBAL PVC BLOOD BAGS MARKET SIZE, BY OFFLINE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 101. GLOBAL PVC BLOOD BAGS MARKET SIZE, BY OFFLINE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 102. GLOBAL PVC BLOOD BAGS MARKET SIZE, BY OFFLINE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 103. GLOBAL PVC BLOOD BAGS MARKET SIZE, BY ONLINE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 104. GLOBAL PVC BLOOD BAGS MARKET SIZE, BY ONLINE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 105. GLOBAL PVC BLOOD BAGS MARKET SIZE, BY ONLINE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 106. GLOBAL PVC BLOOD BAGS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 107. AMERICAS PVC BLOOD BAGS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 108. AMERICAS PVC BLOOD BAGS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 109. AMERICAS PVC BLOOD BAGS MARKET SIZE, BY BLOOD COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 110. AMERICAS PVC BLOOD BAGS MARKET SIZE, BY PLASMA BAG, 2018-2032 (USD MILLION)
  • TABLE 111. AMERICAS PVC BLOOD BAGS MARKET SIZE, BY PLATELET BAG, 2018-2032 (USD MILLION)
  • TABLE 112. AMERICAS PVC BLOOD BAGS MARKET SIZE, BY RED CELL BAG, 2018-2032 (USD MILLION)
  • TABLE 113. AMERICAS PVC BLOOD BAGS MARKET SIZE, BY STERILIZATION TECHNIQUE, 2018-2032 (USD MILLION)
  • TABLE 114. AMERICAS PVC BLOOD BAGS MARKET SIZE, BY PORT CONFIGURATION, 2018-2032 (USD MILLION)
  • TABLE 115. AMERICAS PVC BLOOD BAGS MARKET SIZE, BY PRICE RANGE, 2018-2032 (USD MILLION)
  • TABLE 116. AMERICAS PVC BLOOD BAGS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 117. AMERICAS PVC BLOOD BAGS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 118. AMERICAS PVC BLOOD BAGS MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 119. NORTH AMERICA PVC BLOOD BAGS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 120. NORTH AMERICA PVC BLOOD BAGS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 121. NORTH AMERICA PVC BLOOD BAGS MARKET SIZE, BY BLOOD COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 122. NORTH AMERICA PVC BLOOD BAGS MARKET SIZE, BY PLASMA BAG, 2018-2032 (USD MILLION)
  • TABLE 123. NORTH AMERICA PVC BLOOD BAGS MARKET SIZE, BY PLATELET BAG, 2018-2032 (USD MILLION)
  • TABLE 124. NORTH AMERICA PVC BLOOD BAGS MARKET SIZE, BY RED CELL BAG, 2018-2032 (USD MILLION)
  • TABLE 125. NORTH AMERICA PVC BLOOD BAGS MARKET SIZE, BY STERILIZATION TECHNIQUE, 2018-2032 (USD MILLION)
  • TABLE 126. NORTH AMERICA PVC BLOOD BAGS MARKET SIZE, BY PORT CONFIGURATION, 2018-2032 (USD MILLION)
  • TABLE 127. NORTH AMERICA PVC BLOOD BAGS MARKET SIZE, BY PRICE RANGE, 2018-2032 (USD MILLION)
  • TABLE 128. NORTH AMERICA PVC BLOOD BAGS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 129. NORTH AMERICA PVC BLOOD BAGS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 130. NORTH AMERICA PVC BLOOD BAGS MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 131. LATIN AMERICA PVC BLOOD BAGS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 132. LATIN AMERICA PVC BLOOD BAGS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 133. LATIN AMERICA PVC BLOOD BAGS MARKET SIZE, BY BLOOD COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 134. LATIN AMERICA PVC BLOOD BAGS MARKET SIZE, BY PLASMA BAG, 2018-2032 (USD MILLION)
  • TABLE 135. LATIN AMERICA PVC BLOOD BAGS MARKET SIZE, BY PLATELET BAG, 2018-2032 (USD MILLION)
  • TABLE 136. LATIN AMERICA PVC BLOOD BAGS MARKET SIZE, BY RED CELL BAG, 2018-2032 (USD MILLION)
  • TABLE 137. LATIN AMERICA PVC BLOOD BAGS MARKET SIZE, BY STERILIZATION TECHNIQUE, 2018-2032 (USD MILLION)
  • TABLE 138. LATIN AMERICA PVC BLOOD BAGS MARKET SIZE, BY PORT CONFIGURATION, 2018-2032 (USD MILLION)
  • TABLE 139. LATIN AMERICA PVC BLOOD BAGS MARKET SIZE, BY PRICE RANGE, 2018-2032 (USD MILLION)
  • TABLE 140. LATIN AMERICA PVC BLOOD BAGS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 141. LATIN AMERICA PVC BLOOD BAGS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 142. LATIN AMERICA PVC BLOOD BAGS MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 143. EUROPE, MIDDLE EAST & AFRICA PVC BLOOD BAGS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 144. EUROPE, MIDDLE EAST & AFRICA PVC BLOOD BAGS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 145. EUROPE, MIDDLE EAST & AFRICA PVC BLOOD BAGS MARKET SIZE, BY BLOOD COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 146. EUROPE, MIDDLE EAST & AFRICA PVC BLOOD BAGS MARKET SIZE, BY PLASMA BAG, 2018-2032 (USD MILLION)
  • TABLE 147. EUROPE, MIDDLE EAST & AFRICA PVC BLOOD BAGS MARKET SIZE, BY PLATELET BAG, 2018-2032 (USD MILLION)
  • TABLE 148. EUROPE, MIDDLE EAST & AFRICA PVC BLOOD BAGS MARKET SIZE, BY RED CELL BAG, 2018-2032 (USD MILLION)
  • TABLE 149. EUROPE, MIDDLE EAST & AFRICA PVC BLOOD BAGS MARKET SIZE, BY STERILIZATION TECHNIQUE, 2018-2032 (USD MILLION)
  • TABLE 150. EUROPE, MIDDLE EAST & AFRICA PVC BLOOD BAGS MARKET SIZE, BY PORT CONFIGURATION, 2018-2032 (USD MILLION)
  • TABLE 151. EUROPE, MIDDLE EAST & AFRICA PVC BLOOD BAGS MARKET SIZE, BY PRICE RANGE, 2018-2032 (USD MILLION)
  • TABLE 152. EUROPE, MIDDLE EAST & AFRICA PVC BLOOD BAGS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 153. EUROPE, MIDDLE EAST & AFRICA PVC BLOOD BAGS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 154. EUROPE, MIDDLE EAST & AFRICA PVC BLOOD BAGS MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 155. EUROPE PVC BLOOD BAGS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 156. EUROPE PVC BLOOD BAGS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 157. EUROPE PVC BLOOD BAGS MARKET SIZE, BY BLOOD COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 158. EUROPE PVC BLOOD BAGS MARKET SIZE, BY PLASMA BAG, 2018-2032 (USD MILLION)
  • TABLE 159. EUROPE PVC BLOOD BAGS MARKET SIZE, BY PLATELET BAG, 2018-2032 (USD MILLION)
  • TABLE 160. EUROPE PVC BLOOD BAGS MARKET SIZE, BY RED CELL BAG, 2018-2032 (USD MILLION)
  • TABLE 161. EUROPE PVC BLOOD BAGS MARKET SIZE, BY STERILIZATION TECHNIQUE, 2018-2032 (USD MILLION)
  • TABLE 162. EUROPE PVC BLOOD BAGS MARKET SIZE, BY PORT CONFIGURATION, 2018-2032 (USD MILLION)
  • TABLE 163. EUROPE PVC BLOOD BAGS MARKET SIZE, BY PRICE RANGE, 2018-2032 (USD MILLION)
  • TABLE 164. EUROPE PVC BLOOD BAGS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 165. EUROPE PVC BLOOD BAGS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 166. EUROPE PVC BLOOD BAGS MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 167. MIDDLE EAST PVC BLOOD BAGS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 168. MIDDLE EAST PVC BLOOD BAGS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 169. MIDDLE EAST PVC BLOOD BAGS MARKET SIZE, BY BLOOD COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 170. MIDDLE EAST PVC BLOOD BAGS MARKET SIZE, BY PLASMA BAG, 2018-2032 (USD MILLION)
  • TABLE 171. MIDDLE EAST PVC BLOOD BAGS MARKET SIZE, BY PLATELET BAG, 2018-2032 (USD MILLION)
  • TABLE 172. MIDDLE EAST PVC BLOOD BAGS MARKET SIZE, BY RED CELL BAG, 2018-2032 (USD MILLION)
  • TABLE 173. MIDDLE EAST PVC BLOOD BAGS MARKET SIZE, BY STERILIZATION TECHNIQUE, 2018-2032 (USD MILLION)
  • TABLE 174. MIDDLE EAST PVC BLOOD BAGS MARKET SIZE, BY PORT CONFIGURATION, 2018-2032 (USD MILLION)
  • TABLE 175. MIDDLE EAST PVC BLOOD BAGS MARKET SIZE, BY PRICE RANGE, 2018-2032 (USD MILLION)
  • TABLE 176. MIDDLE EAST PVC BLOOD BAGS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 177. MIDDLE EAST PVC BLOOD BAGS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 178. MIDDLE EAST PVC BLOOD BAGS MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 179. AFRICA PVC BLOOD BAGS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 180. AFRICA PVC BLOOD BAGS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 181. AFRICA PVC BLOOD BAGS MARKET SIZE, BY BLOOD COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 182. AFRICA PVC BLOOD BAGS MARKET SIZE, BY PLASMA BAG, 2018-2032 (USD MILLION)
  • TABLE 183. AFRICA PVC BLOOD BAGS MARKET SIZE, BY PLATELET BAG, 2018-2032 (USD MILLION)
  • TABLE 184. AFRICA PVC BLOOD BAGS MARKET SIZE, BY RED CELL BAG, 2018-2032 (USD MILLION)
  • TABLE 185. AFRICA PVC BLOOD BAGS MARKET SIZE, BY STERILIZATION TECHNIQUE, 2018-2032 (USD MILLION)
  • TABLE 186. AFRICA PVC BLOOD BAGS MARKET SIZE, BY PORT CONFIGURATION, 2018-2032 (USD MILLION)
  • TABLE 187. AFRICA PVC BLOOD BAGS MARKET SIZE, BY PRICE RANGE, 2018-2032 (USD MILLION)
  • TABLE 188. AFRICA PVC BLOOD BAGS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 189. AFRICA PVC BLOOD BAGS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 190. AFRICA PVC BLOOD BAGS MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 191. ASIA-PACIFIC PVC BLOOD BAGS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 192. ASIA-PACIFIC PVC BLOOD BAGS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 193. ASIA-PACIFIC PVC BLOOD BAGS MARKET SIZE, BY BLOOD COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 194. ASIA-PACIFIC PVC BLOOD BAGS MARKET SIZE, BY PLASMA BAG, 2018-2032 (USD MILLION)
  • TABLE 195. ASIA-PACIFIC PVC BLOOD BAGS MARKET SIZE, BY PLATELET BAG, 2018-2032 (USD MILLION)
  • TABLE 196. ASIA-PACIFIC PVC BLOOD BAGS MARKET SIZE, BY RED CELL BAG, 2018-2032 (USD MILLION)
  • TABLE 197. ASIA-PACIFIC PVC BLOOD BAGS MARKET SIZE, BY STERILIZATION TECHNIQUE, 2018-2032 (USD MILLION)
  • TABLE 198. ASIA-PACIFIC PVC BLOOD BAGS MARKET SIZE, BY PORT CONFIGURATION, 2018-2032 (USD MILLION)
  • TABLE 199. ASIA-PACIFIC PVC BLOOD BAGS MARKET SIZE, BY PRICE RANGE, 2018-2032 (USD MILLION)
  • TABLE 200. ASIA-PACIFIC PVC BLOOD BAGS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 201. ASIA-PACIFIC PVC BLOOD BAGS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 202. ASIA-PACIFIC PVC BLOOD BAGS MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 203. GLOBAL PVC BLOOD BAGS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 204. ASEAN PVC BLOOD BAGS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 205. ASEAN PVC BLOOD BAGS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 206. ASEAN PVC BLOOD BAGS MARKET SIZE, BY BLOOD COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 207. ASEAN PVC BLOOD BAGS MARKET SIZE, BY PLASMA BAG, 2018-2032 (USD MILLION)
  • TABLE 208. ASEAN PVC BLOOD BAGS MARKET SIZE, BY PLATELET BAG, 2018-2032 (USD MILLION)
  • TABLE 209. ASEAN PVC BLOOD BAGS MARKET SIZE, BY RED CELL BAG, 2018-2032 (USD MILLION)
  • TABLE 210. ASEAN PVC BLOOD BAGS MARKET SIZE, BY STERILIZATION TECHNIQUE, 2018-2032 (USD MILLION)
  • TABLE 211. ASEAN PVC BLOOD BAGS MARKET SIZE, BY PORT CONFIGURATION, 2018-2032 (USD MILLION)
  • TABLE 212. ASEAN PVC BLOOD BAGS MARKET SIZE, BY PRICE RANGE, 2018-2032 (USD MILLION)
  • TABLE 213. ASEAN PVC BLOOD BAGS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 214. ASEAN PVC BLOOD BAGS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 215. ASEAN PVC BLOOD BAGS MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 216. GCC PVC BLOOD BAGS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 217. GCC PVC BLOOD BAGS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 218. GCC PVC BLOOD BAGS MARKET SIZE, BY BLOOD COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 219. GCC PVC BLOOD BAGS MARKET SIZE, BY PLASMA BAG, 2018-2032 (USD MILLION)
  • TABLE 220. GCC PVC BLOOD BAGS MARKET SIZE, BY PLATELET BAG, 2018-2032 (USD MILLION)
  • TABLE 221. GCC PVC BLOOD BAGS MARKET SIZE, BY RED CELL BAG, 2018-2032 (USD MILLION)
  • TABLE 222. GCC PVC BLOOD BAGS MARKET SIZE, BY STERILIZATION TECHNIQUE, 2018-2032 (USD MILLION)
  • TABLE 223. GCC PVC BLOOD BAGS MARKET SIZE, BY PORT CONFIGURATION, 2018-2032 (USD MILLION)
  • TABLE 224. GCC PVC BLOOD BAGS MARKET SIZE, BY PRICE RANGE, 2018-2032 (USD MILLION)
  • TABLE 225. GCC PVC BLOOD BAGS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 226. GCC PVC BLOOD BAGS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 227. GCC PVC BLOOD BAGS MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 228. EUROPEAN UNION PVC BLOOD BAGS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 229. EUROPEAN UNION PVC BLOOD BAGS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 230. EUROPEAN UNION PVC BLOOD BAGS MARKET SIZE, BY BLOOD COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 231. EUROPEAN UNION PVC BLOOD BAGS MARKET SIZE, BY PLASMA BAG, 2018-2032 (USD MILLION)
  • TABLE 232. EUROPEAN UNION PVC BLOOD BAGS MARKET SIZE, BY PLATELET BAG, 2018-2032 (USD MILLION)
  • TABLE 233. EUROPEAN UNION PVC BLOOD BAGS MARKET SIZE, BY RED CELL BAG, 2018-2032 (USD MILLION)
  • TABLE 234. EUROPEAN UNION PVC BLOOD BAGS MARKET SIZE, BY STERILIZATION TECHNIQUE, 2018-2032 (USD MILLION)
  • TABLE 235. EUROPEAN UNION PVC BLOOD BAGS MARKET SIZE, BY PORT CONFIGURATION, 2018-2032 (USD MILLION)
  • TABLE 236. EUROPEAN UNION PVC BLOOD BAGS MARKET SIZE, BY PRICE RANGE, 2018-2032 (USD MILLION)
  • TABLE 237. EUROPEAN UNION PVC BLOOD BAGS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 238. EUROPEAN UNION PVC BLOOD BAGS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 239. EUROPEAN UNION PVC BLOOD BAGS MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 240. BRICS PVC BLOOD BAGS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 241. BRICS PVC BLOOD BAGS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 242. BRICS PVC BLOOD BAGS MARKET SIZE, BY BLOOD COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 243. BRICS PVC BLOOD BAGS MARKET SIZE, BY PLASMA BAG, 2018-2032 (USD MILLION)
  • TABLE 244. BRICS PVC BLOOD BAGS MARKET SIZE, BY PLATELET BAG, 2018-2032 (USD MILLION)
  • TABLE 245. BRICS PVC BLOOD BAGS MARKET SIZE, BY RED CELL BAG, 2018-2032 (USD MILLION)
  • TABLE 246. BRICS PVC BLOOD BAGS MARKET SIZE, BY STERILIZATION TECHNIQUE, 2018-2032 (USD MILLION)
  • TABLE 247. BRICS PVC BLOOD BAGS MARKET SIZE, BY PORT CONFIGURATION, 2018-2032 (USD MILLION)
  • TABLE 248. BRICS PVC BLOOD BAGS MARKET SIZE, BY PRICE RANGE, 2018-2032 (USD MILLION)
  • TABLE 249. BRICS PVC BLOOD BAGS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 250. BRICS PVC BLOOD BAGS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 251. BRICS PVC BLOOD BAGS MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 252. G7 PVC BLOOD BAGS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 253. G7 PVC BLOOD BAGS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 254. G7 PVC BLOOD BAGS MARKET SIZE, BY BLOOD COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 255. G7 PVC BLOOD BAGS MARKET SIZE, BY PLASMA BAG, 2018-2032 (USD MILLION)
  • TABLE 256. G7 PVC BLOOD BAGS MARKET SIZE, BY PLATELET BAG, 2018-2032 (USD MILLION)
  • TABLE 257. G7 PVC BLOOD BAGS MARKET SIZE, BY RED CELL BAG, 2018-2032 (USD MILLION)
  • TABLE 258. G7 PVC BLOOD BAGS MARKET SIZE, BY STERILIZATION TECHNIQUE, 2018-2032 (USD MILLION)
  • TABLE 259. G7 PVC BLOOD BAGS MARKET SIZE, BY PORT CONFIGURATION, 2018-2032 (USD MILLION)
  • TABLE 260. G7 PVC BLOOD BAGS MARKET SIZE, BY PRICE RANGE, 2018-2032 (USD MILLION)
  • TABLE 261. G7 PVC BLOOD BAGS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 262. G7 PVC BLOOD BAGS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 263. G7 PVC BLOOD BAGS MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 264. NATO PVC BLOOD BAGS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 265. NATO PVC BLOOD BAGS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 266. NATO PVC BLOOD BAGS MARKET SIZE, BY BLOOD COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 267. NATO PVC BLOOD BAGS MARKET SIZE, BY PLASMA BAG, 2018-2032 (USD MILLION)
  • TABLE 268. NATO PVC BLOOD BAGS MARKET SIZE, BY PLATELET BAG, 2018-2032 (USD MILLION)
  • TABLE 269. NATO PVC BLOOD BAGS MARKET SIZE, BY RED CELL BAG, 2018-2032 (USD MILLION)
  • TABLE 270. NATO PVC BLOOD BAGS MARKET SIZE, BY STERILIZATION TECHNIQUE, 2018-2032 (USD MILLION)
  • TABLE 271. NATO PVC BLOOD BAGS MARKET SIZE, BY PORT CONFIGURATION, 2018-2032 (USD MILLION)
  • TABLE 272. NATO PVC BLOOD BAGS MARKET SIZE, BY PRICE RANGE, 2018-2032 (USD MILLION)
  • TABLE 273. NATO PVC BLOOD BAGS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 274. NATO PVC BLOOD BAGS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 275. NATO PVC BLOOD BAGS MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 276. GLOBAL PVC BLOOD BAGS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 277. UNITED STATES PVC BLOOD BAGS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 278. UNITED STATES PVC BLOOD BAGS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 279. UNITED STATES PVC BLOOD BAGS MARKET SIZE, BY BLOOD COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 280. UNITED STATES PVC BLOOD BAGS MARKET SIZE, BY PLASMA BAG, 2018-2032 (USD MILLION)
  • TABLE 281. UNITED STATES PVC BLOOD BAGS MARKET SIZE, BY PLATELET BAG, 2018-2032 (USD MILLION)
  • TABLE 282. UNITED STATES PVC BLOOD BAGS MARKET SIZE, BY RED CELL BAG, 2018-2032 (USD MILLION)
  • TABLE 283. UNITED STATES PVC BLOOD BAGS MARKET SIZE, BY STERILIZATION TECHNIQUE, 2018-2032 (USD MILLION)
  • TABLE 284. UNITED STATES PVC BLOOD BAGS MARKET SIZE, BY PORT CONFIGURATION, 2018-2032 (USD MILLION)
  • TABLE 285. UNITED STATES PVC BLOOD BAGS MARKET SIZE, BY PRICE RANGE, 2018-2032 (USD MILLION)
  • TABLE 286. UNITED STATES PVC BLOOD BAGS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 287. UNITED STATES PVC BLOOD BAGS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 288. UNITED STATES PVC BLOOD BAGS MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 289. CHINA PVC BLOOD BAGS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 290. CHINA PVC BLOOD BAGS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 291. CHINA PVC BLOOD BAGS MARKET SIZE, BY BLOOD COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 292. CHINA PVC BLOOD BAGS MARKET SIZE, BY PLASMA BAG, 2018-2032 (USD MILLION)
  • TABLE 293. CHINA PVC BLOOD BAGS MARKET SIZE, BY PLATELET BAG, 2018-2032 (USD MILLION)
  • TABLE 294. CHINA PVC BLOOD BAGS MARKET SIZE, BY RED CELL BAG, 2018-2032 (USD MILLION)
  • TABLE 295. CHINA PVC BLOOD BAGS MARKET SIZE, BY STERILIZATION TECHNIQUE, 2018-2032 (USD MILLION)
  • TABLE 296. CHINA PVC BLOOD BAGS MARKET SIZE, BY PORT CONFIGURATION, 2018-2032 (USD MILLION)
  • TABLE 297. CHINA PVC BLOOD BAGS MARKET SIZE, BY PRICE RANGE, 2018-2032 (USD MILLION)
  • TABLE 298. CHINA PVC BLOOD BAGS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 299. CHINA PVC BLOOD BAGS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 300. CHINA PVC BLOOD BAGS MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)